Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | GPR3 | P46089 | 1/20 | 0.45 |
| ▸ | TOP2A | P11388 | 1/20 | 0.44 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.38 |
| ▸ | CDK4 | P11802 | 1/20 | 0.38 |
| ▸ | CCND1 | P24385 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19007826 | 0.78 | GPR3 (0.52) | CYP1A2KDM4EGPR3TOP2A | |
| SCHEMBL23028710 | 0.77 | KDM4E (0.57) | CYP1A2KDM4EGPR3TOP2APDPK1 | |
| SCHEMBL1103243 | 0.76 | TOP2A (0.51) | CYP1A2KDM4EGPR3TOP2APDPK1 | |
| SCHEMBL16535871 | 0.74 | GPR3 (0.52) | CYP1A2KDM4EGPR3TOP2APDPK1 | |
| SCHEMBL19007829 | 0.73 | CCR1 (0.50) | KDM4EGPR3TOP2ANPC1TLR7 | |
| SCHEMBL19020845 | 0.73 | GPR3 (0.68) | KDM4EGPR3TOP2APDPK1NPC1 | |
| SCHEMBL3156746 | 0.72 | CCR1 (0.52) | CYP1A2KDM4EGPR3TOP2ATLR7 | |
| SCHEMBL22048797 | 0.72 | GPR3 (0.50) | KDM4EGPR3TOP2APDPK1NPC1 | |
| SCHEMBL29661797 | 0.72 | CCR1 (0.52) | CYP1A2KDM4EGPR3TOP2ATLR7 | |
| SCHEMBL1103265 | 0.72 | NPC1 (0.50) | KDM4EGPR3TOP2APDPK1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130027636-A1 | CLASS OF BRIDGED BIPHENYLENE POLYMERS | SUMITOMO CHEMICAL CO., LTD. (JP) | 2013-01-31 | — | — | US | disclosed |
| US-20130027636-A1 | CLASS OF BRIDGED BIPHENYLENE POLYMERS | SUMITOMO CHEMICAL CO., LTD. (JP) | 2013-01-31 | — | — | US | disclosed |
| US-20120264977-A1 | TRIARYLAMINE CONTAINING POLYMERS AND ELECTRONIC DEVICES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-18 | — | — | US | disclosed |
| US-20120264977-A1 | TRIARYLAMINE CONTAINING POLYMERS AND ELECTRONIC DEVICES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-18 | — | — | US | disclosed |
| US-8247800-B2 | Triarylamine containing polymers and electronic devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-21 | — | — | US | disclosed |
| US-8247800-B2 | Triarylamine containing polymers and electronic devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-21 | — | — | US | disclosed |
| US-20120010359-A1 | SALICYLATE SUBSTITUTED CONJUGATED POLYMERS AND DEVICES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-12 | — | — | US | disclosed |
| US-20120010359-A1 | SALICYLATE SUBSTITUTED CONJUGATED POLYMERS AND DEVICES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-12 | — | — | US | disclosed |
| US-8052894-B2 | Salicylate substituted conjugated polymers and devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-11-08 | — | — | US | disclosed |
| US-8052894-B2 | Salicylate substituted conjugated polymers and devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-11-08 | — | — | US | disclosed |
| US-20090066224-A1 | DICARBAZOLE AROMATIC AMINE POLYMERS AND ELECTRONIC DEVICES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-03-12 | — | — | US | disclosed |
| US-20090001324-A1 | Salicylate Substituted Conjugated Polymers and Devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-01-01 | — | — | US | disclosed |
| US-20090001324-A1 | Salicylate Substituted Conjugated Polymers and Devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-01-01 | — | — | US | disclosed |
| US-20080265755-A1 | Biscarbazol-9-Yl-Substituted Triarylamine-Containing Polymers and Electronic Devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080265755-A1 | Biscarbazol-9-Yl-Substituted Triarylamine-Containing Polymers and Electronic Devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-10-30 | — | — | US | disclosed |
| US-20080011353-A1 | Triarylamine Containing Polymers and Electronic Devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-01-17 | — | — | US | disclosed |
| US-20080011353-A1 | Triarylamine Containing Polymers and Electronic Devices | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2008-01-17 | — | — | US | disclosed |
| EP-1576032-B1 | TRICYCLIC ARYLAMINE MONOMER AND POLYMERS AND DEVICES THEREOF | DOW GLOBAL TECHNOLOGIES INC (US) | 2007-10-17 | — | — | EP | disclosed |
| US-20070102695-A1 | Crosslinkable substituted fluorene compounds and conjugated oligomers or polymers based thereon | DOW GLOBAL TECHNOLOGIES INC. | 2007-05-10 | — | — | US | disclosed |
| US-20070102695-A1 | Crosslinkable substituted fluorene compounds and conjugated oligomers or polymers based thereon | DOW GLOBAL TECHNOLOGIES INC. | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090066224-A1 | DICARBAZOLE AROMATIC AMINE POLYMERS AND ELECTRONIC DEVICES | NAT1, SAT1, RIF1 | CYP1A2 361/4885KDM4E 1909/4885GPR3 499/4885 |
| US-20120264977-A1 | TRIARYLAMINE CONTAINING POLYMERS AND ELECTRONIC DEVICES | NAT1, AHR, AR | CYP1A2 309/4885KDM4E 1876/4885GPR3 258/4885 |
| US-20070102695-A1 | Crosslinkable substituted fluorene compounds and conjugated oligomers or polymers based thereon | THEM6, PCNA, PARG | CYP1A2 2904/4885KDM4E 4244/4885GPR3 3957/4885 |
| US-20090001324-A1 | Salicylate Substituted Conjugated Polymers and Devices | TLR9, TLR5, TLR1 | CYP1A2 950/4885KDM4E 2100/4885GPR3 3727/4885 |
| US-20080265755-A1 | Biscarbazol-9-Yl-Substituted Triarylamine-Containing Polymers and Electronic Devices | PYM1, KCNMB4, BRD9 | CYP1A2 516/4885KDM4E 503/4885GPR3 2245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.